Surrozen, Inc.

171 Oyster Point Boulevard
Suite 400
South San Francisco
United States

Tel: 650-475-2820

Featured Employer
NextGen Class of 2018
Show articles for this employer

About Surrozen, Inc.

Repair. Restore. Renew

Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway. Surrozen is at pre-clinical stage, and anticipates its first clinical trials will be underway in 2022.  Surrozen (SRZN) became publicly traded in August of 2021. 


Our inclusive and pioneering culture creates a sense of belonging, impact, adventure and fun.  Join us and Collaborate, Lead, Innovate Motivate and be Brave, Open and Nurturing at Surrozen!   
Total Rewards

Surrozen offers a competitive total rewards package that includes:

  • Health and welfare benefits
  • Generous vacation, sick leave, and company paid holidays
  • 401k match
  • Company sponsored events, adventures and weekly lunches
  • Bring your dog to work Fridays

Surrozen - Empowered Patient

Craig Parker is the Chief Executive Officer at Surrozen. Their research in the Wnt pathway and proteins identified these are critical to maintaining tissues in our body and are found in tissues as diverse as the lung, intestine, liver, sensory hair cells, and the eye.

Surrozen - Climb On

New Company Values

A committee of Surrozen employees put their heads together and came up with our new company values.  In every project we take on these 7 keys words are at the forefront.  CLIMB ON!!!

Currently, there are no jobs for this employer on BioSpace.

Browse jobs with BioSpace Featured Employers here.